Judith M Bliss

13PUBLICATIONS
195CO-AUTHORS
Predictive and prognostic markersTissue engineeringRadiation therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 28, 2026
A Randomized, Phase II Clinical Trial of FLT-PET and FDG-PET for Early Response Assessment of Neoadjuvant Systemic Therapy in Triple Negative Breast Cancer.

|Dec 16, 2025
Author Correction: Advancing equitable access to innovation in breast cancer.

Seamus O'Reilly, Ines Vaz Luis, Virginie Adam

|Oct 29, 2025
The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial.

Iseult M Browne, Javier Pascual, Rosalind J Cutts

|Jul 10, 2025
Advancing equitable access to innovation in breast cancer.

Seamus O'Reilly, Ines Vaz Luis, Virginie Adam

|Sep 11, 2024
Adjuvant Pertuzumab and Trastuzumab in Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the APHINITY Trial: Third Interim Overall Survival Analysis With Efficacy Update.

Sibylle Loibl, Jacek Jassem, Amir Sonnenblick

|Dec 11, 2023
Comparison of Circulating Tumor DNA Assays for Molecular Residual Disease Detection in Early-Stage Triple-Negative Breast Cancer.

Maria Coakley, Guillermo Villacampa, Prithika Sritharan

Pageof 3

Frequent Collaborators

5 joint publications

Lucy S Kilburn

4 joint publications

Iain R Macpherson

4 joint publications

Nicolas C Turner

3 joint publications

Laura Moretti